Rating History for Protalix BioTherapeutics (PLX) by Wells Fargo

More Stocks Rated by Wells Fargo | Latest Ratings for PLX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/25/2012 N/A Downgrade Equal Weight
(Overweight)		 N/A
(N/A)		 6.19
(2.31)		 -62.68% Details